USPTO Examiner TOWA RENE T - Art Unit 3791

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17125320MEDICAL INSTRUMENT WITH SHAFT ACTUATING HANDLE CONFIGURED TO ACCEPT STYLETDecember 2020July 2024Abandon4320YesNo
17102491BIOPSY NEEDLE ASSEMBLY AND METHODNovember 2020December 2024Abandon4930NoNo
17096985DIAGNOSTIC MEASUREMENT DEVICES AND METHODSNovember 2020March 2023Abandon2810NoNo
17089461SKIN BIOPSY DEVICENovember 2020July 2023Allow3210NoNo
17089632TISSUE ACQUISITION HELIX DEVICENovember 2020May 2024Allow4220NoNo
17086113SYSTEMS AND METHODS FOR DIAGNOSIS AND TREATMENT OF SWALLOWING DISORDERS WITH GAMIFICATIONOctober 2020September 2024Allow4740YesNo
16949401NEEDLE BIOPSY DEVICEOctober 2020August 2023Abandon3420NoNo
17082387Biopsy System with a Core Collector that Remains Radially Centered in an Outer Cannula While Severing a Tissue SampleOctober 2020December 2023Allow3820YesNo
17069422MEDICAL DEVICE FOR CONCURRENT COLLECTION OF MULTIPLE TISSUE SAMPLESOctober 2020June 2024Allow4430YesNo
17041046FOLLICULAR CONTENT STORAGESeptember 2020February 2024Abandon4110NoNo
17016529Rotary Oblique-Cutting Biopsy NeedleSeptember 2020June 2023Abandon3420NoNo
17001796High Sensitivity Movement Disorder Treatment Device or SystemAugust 2020September 2022Allow2510NoNo
16968540NEEDLE TIPS, NEEDLES FOR TISSUE COLLECTION, METHODS OF FABRICATION, AND METHODS OF USEAugust 2020December 2022Abandon2810NoNo
16902579Device for Biological Cell Collection and Method of UseJune 2020November 2024Allow5370YesNo
16866274Shape Sensing Biopsy NeedleMay 2020September 2023Allow4010NoNo
16854287UNIT FOR COLLECTING BLOODApril 2020May 2024Abandon4950NoNo
16853016DEVICES AND METHODS FOR OBTAINING ADENOMYOSIS AND OTHER BIOPSY SAMPLESApril 2020July 2023Allow3820NoNo
16849538MEDICAL TESTING APPARATUS AND METHOD OF USEApril 2020April 2024Allow4850YesYes
16645779SENSOR ENABLED WOUND THERAPY DRESSINGS AND SYSTEMS IMPLEMENTING CYBERSECURITYMarch 2020February 2023Allow3510NoNo
16810997CYTOLOGY SAMPLING SYSTEM AND METHOD OF UTILIZING THE SAMEMarch 2020September 2022Allow3100NoNo
16644291Steerable Catheter with Portions of Different StiffnessMarch 2020July 2023Abandon4020NoNo
16789617MARKER DELIVERY DEVICE WITH STERILE GUIDEFebruary 2020March 2024Allow4940YesNo
16633888MAGNETIC ROBOTJanuary 2020January 2023Allow3510NoNo
16630062SYSTEM FOR MEASURING THE ELECTRICAL IMPEDANCE IN HUMAN TISSUESJanuary 2020August 2023Abandon4340YesNo
16731025VIDEO-BASED FALL RISK ASSESSMENT SYSTEMDecember 2019April 2025Abandon6060YesNo
16618362SENSOR APPLICATOR ASSEMBLY FOR CONTINUOUS GLUCOSE MONITORING SYSTEMDecember 2019September 2021Allow2220NoNo
16611477DEVICES AND METHODS FOR COLLECTING GASTROINTESTINAL SAMPLESNovember 2019May 2023Allow4240YesNo
16670047DEVICE AND PROCESS FOR ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT) WITH IDENTIFICATION OF A HEART REGIONOctober 2019September 2024Abandon5960YesNo
16591802SYSTEM AND METHOD OF DETECTING SLEEP DISORDERSOctober 2019February 2023Allow4120NoNo
16495933Sensing System for Pericardial AccessSeptember 2019July 2022Abandon3440NoYes
16571226Method for measuring exerciseSeptember 2019August 2022Allow3510NoNo
16493584VARIABLE STIFFNESS NEEDLESeptember 2019July 2023Abandon4660YesNo
16493043AIRWAY SIZING APPARATUSSeptember 2019March 2023Abandon4220NoNo
16486299JAW ASSEMBLY FOR SURGICAL TOOL AND BIOPSY SAMPLE COLLECTION MEMBERAugust 2019July 2024Abandon5930YesNo
16483951POSITION DETECTION BASED ON TISSUE DISCRIMINATIONAugust 2019March 2022Allow3120YesYes
16530925Systems and Methods for Performing Neurophysiologic MonitoringAugust 2019August 2022Allow3610YesNo
16481401CUTTING BIOPSY INSTRUMENTJuly 2019October 2021Allow2710NoNo
16508899STIMULATOR HANDPIECE FOR AN EVOKED POTENTIAL MONITORING SYSTEMJuly 2019July 2022Allow3610NoNo
16505629Mobile Control Using Gait CadenceJuly 2019August 2022Allow3760YesNo
16475732CORE BIOPSY SYSTEM FOR STORAGE AND PRESERVATION OF MULTIPLE TISSUE SAMPLESJuly 2019November 2022Allow4110NoNo
16445389TISSUE SAMPLE HOLDER WITH ENHANCED FLUID MANAGEMENTJune 2019August 2021Allow2610YesNo
16469046TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IL-1 INHIBITORJune 2019June 2023Abandon4920NoNo
16435244MONITORING COMPLIANCE USING VENOUS REFILL DETECTIONJune 2019January 2023Abandon4320YesNo
16467462DEVICES AND METHODS FOR EXTRACTION AND COLLECTION OF TISSUE SAMPLESJune 2019September 2022Allow4010NoNo
16419247SAMPLE RETRIEVAL KIT AND SYSTEM AND METHOD OF USE THEREOFMay 2019December 2022Abandon4301NoNo
16345505A DEVICE COMPRISING A BLOOD PRESSURE SENSOR AND A METHOD FOR CONTROLLING THE DEVICEApril 2019February 2022Allow3430NoYes
16396258INTERNAL ANATOMICAL FORCE MEASUREMENTApril 2019October 2024Abandon6050YesNo
16372720MEASUREMENT DEVICE, SHAPE ESTIMATION DEVICE, MEASUREMENT METHOD, SHAPE ESTIMATION METHOD, AND NON-TRANSITORY RECORDING MEDIUM RECORDING PROGRAMApril 2019June 2022Allow3910NoNo
16361736HYSTEROSCOPIC TISSUE BIOPSY DEVICES, SYSTEMS, AND METHODSMarch 2019December 2022Abandon4420NoNo
16356412DEVICE FOR MEASURING AN AORTIC VALVE ANNULUS IN AN EXPANDED CONDITIONMarch 2019April 2022Allow3710NoNo
16354637BIOPSY DEVICEMarch 2019May 2023Allow5040YesNo
16352096Calibration of an Inertial Measurement Unit for Improving the Accuracy of a Biomechanical SkeletonMarch 2019August 2023Allow5441NoNo
16285938DETECTION OF CONCUSSION USING CRANIAL ACCELEROMETRYFebruary 2019July 2024Abandon6080YesYes
16279384SYSTEM AND METHOD FOR COORDINATED LASER DELIVERY AND IMAGINGFebruary 2019December 2020Allow2200NoNo
16325689Systems and Methods for Assessment of Ocular CyclotorsionFebruary 2019December 2022Allow4610NoNo
16271883Steerable Shape Sensing Biopsy NeedleFebruary 2019April 2022Allow3801NoNo
16322932BREAST SIZE (VOLUME) MEASUREMENT APPARATUSFebruary 2019October 2022Abandon4410NoNo
16258966RADIOFREQUENCY DETECTION AND IDENTIFICATION OF PRESSURE SENSING CATHETERSJanuary 2019September 2021Allow3150YesNo
16321201ULTRASOUND SYSTEM FRONT-END CIRCUIT WITH PULSERS AND LINEAR AMPLIFIERS FOR AN ARRAY TRANSDUCERJanuary 2019March 2022Allow3730YesNo
16320611DENERVATION CATHETERJanuary 2019December 2023Allow5940NoNo
16252772MULTI-FUNCTION DERMATOLOGICAL BIOPSY INSTRUMENTJanuary 2019November 2021Allow3420NoNo
16247265SYSTEMS AND METHODS FOR EVALUATING THE INTEGRITY OF A UTERINE CAVITYJanuary 2019March 2022Allow3820NoYes
16233309Transport System for Biopsy DeviceDecember 2018February 2022Allow3801NoNo
16232594MEASUREMENT DEVICE FOR ASSESSING KNEE MOVEMENTDecember 2018June 2021Abandon3010NoNo
16309730FREE RADICAL CONSUMPTION SPEED INFORMATION ACQUISITION METHOD AND NASH DETERMINATION METHODDecember 2018July 2022Allow4320NoNo
16219509PHOTOACOUSTIC GUIDE SUPPORT SYSTEM AND PHOTOACOUSTIC GUIDE SUPPORT METHODDecember 2018August 2021Abandon3210NoNo
16214928THERMOGRAPHIC DEVICE FOR MEASUREMENT OF DIFFERENTIAL TEMPERATURES IN TISSUEDecember 2018April 2022Allow4130NoNo
16307981MEASUREMENT SYSTEM AND METHOD FOR CHARACTERIZING TISSUEDecember 2018April 2022Abandon4010NoNo
16307995GRAPHICAL USER INTERFACE FOR DISPLAYING GUIDANCE INFORMATION IN A PLURALITY OF MODES DURING AN IMAGE-GUIDED PROCEDUREDecember 2018November 2022Allow4740YesNo
16211603NOVELTY IN BIOPSY VALVE CAP HOLE EMBODIMENTDecember 2018November 2022Abandon4710NoNo
16212100FRICTIONAL TISSUE SAMPLING AND COLLECTION METHOD AND DEVICEDecember 2018May 2022Abandon4140NoNo
16208814BIOPSY DEVICE WITH APPLIED IMAGINGDecember 2018March 2022Allow4031YesNo
16305282PLIANT BIOPSY NEEDLE SYSTEMNovember 2018January 2024Abandon6080YesNo
16194563Ingestible Medical DeviceNovember 2018September 2024Abandon6041YesNo
16195343INTRAOSSEOUS NEEDLE SETSNovember 2018April 2021Allow2910NoNo
16188864AccelerometerNovember 2018October 2020Allow2300NoNo
16180391BIOPSY DEVICENovember 2018November 2021Allow3610NoNo
16095342SYSTEMS AND METHOD FOR SKIN ANALYSIS USING ELECTRONIC DEVICESOctober 2018April 2023Allow5440NoNo
16094551PROTOCOL AND SIGNATURES FOR THE MULTIMODAL PHYSIOLOGICAL STIMULATION AND ASSESSMENT OF TRAUMATIC BRAIN INJURYOctober 2018October 2021Abandon3610NoNo
16107620METHOD AND APPARATUS FOR AN INCREASED GYROSCOPIC RATE SENSORAugust 2018September 2021Abandon3710NoNo
16102283SYSTEM AND METHOD OF TAKING AND COLLECTING TISSUE CORES FOR TREATMENTAugust 2018November 2021Allow3920NoNo
16042515MECHANISMS FOR IMPROVING THE STIFFNESS TRANSITION ACROSS A DISSIMILAR METAL WELD JOINTJuly 2018June 2021Allow3430YesNo
16029251Medical Tool for Reduced Force Penetration for Vascular AccessJuly 2018December 2021Abandon4120NoNo
16018415FRACTURE INDEX DETERMINATION SYSTEM AND METHOD AND STORAGE MEDIUMJune 2018September 2024Abandon6050NoNo
16009956REMOTE CONTROL SWITCH FOR A LASER SYSTEMJune 2018April 2021Allow3410NoNo
15776910CONFORMABLE BIOMECHANICAL FORCE SENSOR AND METHOD OF FABRICATIONMay 2018December 2022Abandon5560NoNo
15767139SYSTEM AND METHOD FOR QUANTIFIABLE SHAVE BIOPSYApril 2018January 2022Abandon4640YesNo
15925652PHYSICAL ACTIVITY AND WORKOUT MONITORMarch 2018November 2020Allow3230YesNo
15902781BIOPSY DEVICEFebruary 2018August 2023Allow6060NoYes
15886293DEVICE FOR NEEDLE BIOPSY WITH INTEGRATED NEEDLE PROTECTIONFebruary 2018December 2021Allow4730YesNo
15885097BIOPSY DEVICE AND METHODJanuary 2018June 2020Allow2960YesNo
15871707PERCUTANEOUS INSTRUMENTS, AND MATERIALS, CONSTRUCTION AND METHODS OF USEJanuary 2018February 2023Abandon6041NoNo
15868148Method and Apparatus for Hysteroscopy and Endometrial BiopsyJanuary 2018June 2019Allow1730YesNo
15862915SYSTEMS, DEVICES AND METHODS FOR TISSUE REMOVAL AND ANALYSISJanuary 2018March 2021Allow3810YesNo
15741263INTRAVASCULAR DEVICES SYSTEMS AND METHODS WITH A SOLID CORE PROXIMAL SECTION AND A SLOTTED TUBULAR DISTAL SECTIONDecember 2017April 2021Abandon3920YesNo
15837605DEVICE FOR SHAPING A GUIDEWIREDecember 2017January 2020Allow2520NoNo
15798969METHODS FOR THE DIAGNOSIS AND TREATMENT OF SJ�GREN'S SYNDROM3October 2017July 2020Allow3321NoNo
15566859SYSTEM AND METHOD FOR CONTROLLING A VALVE OF A PORTABLE MEDICAL DEVICEOctober 2017February 2021Allow4030YesNo
15715033DEVICES AND METHODS FOR AIRWAY MEASUREMENTSeptember 2017September 2020Allow3600NoNo
15707539APPARATUS FOR OBTAINING BIOLOGICAL INFORMATIONSeptember 2017July 2020Abandon3460YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TOWA, RENE T.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
20
Examiner Affirmed
12
(60.0%)
Examiner Reversed
8
(40.0%)
Reversal Percentile
63.6%
Higher than average

What This Means

With a 40.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
49
Allowed After Appeal Filing
13
(26.5%)
Not Allowed After Appeal Filing
36
(73.5%)
Filing Benefit Percentile
39.5%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 26.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner TOWA, RENE T - Prosecution Strategy Guide

Executive Summary

Examiner TOWA, RENE T works in Art Unit 3791 and has examined 238 patent applications in our dataset. With an allowance rate of 63.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 44 months.

Allowance Patterns

Examiner TOWA, RENE T's allowance rate of 63.9% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by TOWA, RENE T receive 3.56 office actions before reaching final disposition. This places the examiner in the 93% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by TOWA, RENE T is 44 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +0.2% benefit to allowance rate for applications examined by TOWA, RENE T. This interview benefit is in the 19% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.1% of applications are subsequently allowed. This success rate is in the 11% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 16.9% of cases where such amendments are filed. This entry rate is in the 21% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 53.8% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 48% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 55.6% of appeals filed. This is in the 28% percentile among all examiners. Of these withdrawals, 52.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 60.0% are granted (fully or in part). This grant rate is in the 62% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.2% of allowed cases (in the 84% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.